Vincenza Conteduca

Vincenza Conteduca

Medical Oncologist

University Hospital “Ospedali Riuniti”

Location Italy, Foggia

Linkedin

X

Current Position

  • Associate Professor of Oncology (High Specialization in Genitourinary Tumors), University of Foggia, Italy
  • Head of the Oncology Orientation Center (COrO), Unit of Medical Oncology and Biomolecular Therapy, “Ospedali Riuniti” Hospital, Foggia, Italy

Education

  • PhD in Immunorheumatology and Clinical & Experimental Oncology, Bioethics and Cancer Epidemiology – University of Foggia
  • Specialization in Oncology (cum laude) – University of Bari
  • MD, Medicine and Surgery (cum laude) – University of Bari
  • Clinical Fellow – Royal Marsden NHS Foundation Trust, London
  • Executive Training in Oncology Evaluation & Negotiation – SDA Bocconi

Clinical Expertise

  • Genitourinary cancers (prostate, renal, urothelial tumors)
  • Metastatic castration-resistant prostate cancer (mCRPC)
  • Translational oncology and biomarker-driven therapy
  • Liquid biopsy and circulating tumor DNA
  • Personalized and precision oncology approaches

Research & Publications

  • Extensive publication record in leading journals including European Urology, Clinical Cancer Research, and Nature Reviews Urology
  • Key research focus: Molecular heterogeneity in prostate cancer, DNA repair pathways and targeted therapies, Biomarkers and liquid biopsy, Real-world evidence in uro-oncology
  • Contributor to major international multicenter studies (ARON, Meet-URO)
  •  Publications in high-impact journals (IF up to 78+ including NEJM)

Leadership

  • Head, Oncology Orientation Center (COrO), Foggia
  • Faculty Board Member, multiple PhD programs at University of Foggia:
  • Innovative Sciences for Health and Active Ageing
  • Medical Humanities and Welfare Policies
  • Active role in academic teaching across oncology, nursing, and biomedical sciences

Academic Impact

  • International research experience:
  • Dana-Farber Cancer Institute, Harvard Medical School
  • Weill Cornell Medicine, New York
  • Institute of Cancer Research, London
  • Recognized expert in uro-oncology and translational cancer research
  • Strong involvement in global collaborative oncology networks